(Hypertension. 1995;25:162-165.)
© 1995 American Heart Association, Inc.
Articles |
Resetting Blood Pressure in Spontaneously Hypertensive Rats
The Role of Bradykinin
From the Genetic Physiology Unit, Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia.
Correspondence to Joseph B. O'Sullivan, Department of Medicine, University of Melbourne, Austin Hospital, Victoria 3084, Australia.
Abstract Brief angiotensin-converting enzyme (ACE) inhibition in young spontaneously hypertensive rats (SHR) causes a persistent reduction in blood pressure. Bradykinin accumulation may contribute to these long-term effects, and to test this hypothesis we studied the consequences of bradykinin B2 receptor antagonism during ACE inhibitor treatment in young SHR. Male SHR were treated from 6 to 10 weeks of age with water, ramipril (1 mg/kg per day), Hoe 140 (0.5 mg/kg per day), or both ramipril and Hoe 140. Systolic blood pressure and body weight were measured each week from 6 to 20 weeks of age. During treatment, Hoe 140 treatment resulted in lower blood pressures than in controls. Ramipril caused a larger fall in blood pressure over the same period. The ramipril plus Hoe 140 group had the lowest blood pressures of any group during treatment. After treatment, the blood pressure of Hoe 140–treated SHR was similar to that of untreated SHR. After ramipril, blood pressure rose but plateaued significantly below values in controls. In contrast, withdrawal of combined ramipril and Hoe 140 treatment caused a rapid rise of systolic blood pressure to levels significantly higher than in ramipril-treated SHR but less than in controls. The antihypertensive effects of Hoe 140 during the development of genetic hypertension may represent a direct effect of the drug or some alteration in the normal relation between bradykinin and blood pressure. The antagonism by Hoe 140 of the long-term blood pressure reduction after ramipril withdrawal indicates that the persistent effects of ACE inhibitors may in part be due to the accumulation of bradykinin during a critical stage of development.
Key Words: angiotensin-converting enzyme inhibitors • bradykinin • rats • hypertension, genetic
This article has been cited by other articles:
 |
|
 |
|
  A. Dendorfer, S. Wolfrum, M. Wagemann, F. Qadri, and P. Dominiak Pathways of bradykinin degradation in blood and plasma of normotensive and hypertensive rats Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2182 - H2188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Skov, S. Mogensen, and M. J Mulvany Persistent effect of treatment with candesartan cilexetil on blood pressure in spontaneously hypertensive rats Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S91 - S94. [Abstract] [PDF]
|
|
|
|
 |
|
 J. V. Gainer, C. M. Stein, T. Neal, D. E. Vaughan, and N. J. Brown Interactive Effect of Ethnicity and ACE Insertion/Deletion Polymorphism on Vascular Reactivity Hypertension, January 1, 2001; 37(1): 46 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. O'Sullivan and S. B. Harrap Long-Term Effects of Angiotensin-Converting Enzyme Inhibition on Renal Medullary Neutral Lipid in Spontaneously Hypertensive Rats Hypertension, May 1, 1999; 33(5): 1214 - 1217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. W. Dukacz, M. A. Adams, and R. L. Kline Short- and long-term enalapril affect renal medullary hemodynamics in the spontaneously hypertensive rat Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R10 - R16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chen, J. Su, K. Wu, W. Hu, D. G. Gardner, and D. Chen Early captopril treatment prevents hypertrophy-dependent gene expression in hearts of SHR Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1998; 274(6): R1511 - R1517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Partovian, A. Benetos, J.-P. Pommies, W. Mischler, and M. E. Safar Effects of a chronic high-salt diet on large artery structure: role of endogenous bradykinin Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1423 - H1428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Charchar, M. Kapuscinski, and S. B. Harrap Persistent Reduction in Renal Nerve Growth Factor mRNA After Perindopril Treatment of Young Spontaneously Hypertensive Rats Hypertension, February 1, 1998; 31(2): 678 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Colman and A. H. Schmaier Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes Blood, November 15, 1997; 90(10): 3819 - 3843. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Benetos, B. I. Levy, P. Lacolley, F. Taillard, M. Duriez, and M. E. Safar Role of Angiotensin II and Bradykinin on Aortic Collagen Following Converting Enzyme Inhibition in Spontaneously Hypertensive Rats Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3196 - 3201. [Abstract] [Full Text]
|
|
|
|
|
|
B. S. Huang and F. H.H. Leenen Brain "Ouabain" and Angiotensin II in Salt-Sensitive Hypertension in Spontaneously Hypertensive Rats Hypertension, December 1, 1996; 28(6): 1005 - 1012. [Abstract] [Full Text]
|
|
|
|
|
|
S. B. Harrap and J. B. O'Sullivan Cardiac Transplantation, Perindopril, and Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats Hypertension, October 1, 1996; 28(4): 622 - 626. [Abstract] [Full Text]
|
|
|
|
|
|
R. McCarty and J. H. Lee Preweanling Administration of Terazosin Decreases Blood Pressure of Hypertensive Rats in Adulthood Hypertension, May 1, 1996; 27(5): 1115 - 1120. [Abstract] [Full Text]
|
|